- Home
- OGEN vs IMTE Comparison
OGEN vs IMTE Comparison
Compare OGEN & IMTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- IMTE
- Stock Information
- Founded
- OGEN 1996
- IMTE 2008
- Country
- OGEN United States
- IMTE Malaysia
- Employees
- OGEN N/A
- IMTE N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- IMTE Consumer Electronics/Appliances
- Sector
- OGEN Health Care
- IMTE Consumer Staples
- Exchange
- OGEN Nasdaq
- IMTE Nasdaq
- Market Cap
- OGEN 4.6M
- IMTE 4.6M
- IPO Year
- OGEN N/A
- IMTE N/A
- Fundamental
- Price
- OGEN $0.20
- IMTE $1.25
- Analyst Decision
- OGEN
- IMTE
- Analyst Count
- OGEN 0
- IMTE 0
- Target Price
- OGEN N/A
- IMTE N/A
- AVG Volume (30 Days)
- OGEN 376.3K
- IMTE 126.7K
- Earning Date
- OGEN 05-14-2025
- IMTE 05-06-2025
- Dividend Yield
- OGEN N/A
- IMTE N/A
- EPS Growth
- OGEN N/A
- IMTE N/A
- EPS
- OGEN N/A
- IMTE N/A
- Revenue
- OGEN N/A
- IMTE $123,337.00
- Revenue This Year
- OGEN N/A
- IMTE N/A
- Revenue Next Year
- OGEN N/A
- IMTE N/A
- P/E Ratio
- OGEN N/A
- IMTE N/A
- Revenue Growth
- OGEN N/A
- IMTE 4.75
- 52 Week Low
- OGEN $0.16
- IMTE $0.51
- 52 Week High
- OGEN $3.43
- IMTE $3.84
- Technical
- Relative Strength Index (RSI)
- OGEN 43.74
- IMTE 45.10
- Support Level
- OGEN $0.16
- IMTE $1.21
- Resistance Level
- OGEN $0.21
- IMTE $1.30
- Average True Range (ATR)
- OGEN 0.01
- IMTE 0.13
- MACD
- OGEN 0.00
- IMTE -0.03
- Stochastic Oscillator
- OGEN 74.00
- IMTE 8.47
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About IMTE Integrated Media Technology Limited
Integrated Media Technology Ltd is engaged in the development, sale, and distribution of autostereoscopic 3D display, 3D conversion equipment, and software, development, and sale of 3D autostereoscopic technology, and the provision of 3D consultancy services. It operates through the following segments: the sale of electronic glass, sales of air-filter products, sales of Halal products, NFT, corporate, provision of consultancy and provision of new energy products and solutions.